Novo Nordisk
NVO
411 hedge funds and large institutions have $5.8B invested in Novo Nordisk in 2013 Q2 according to their latest regulatory filings, with 411 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
111% more call options, than puts
Call options by funds: $89.1M | Put options by funds: $42.3M
84.64% more ownership
Funds ownership: 0% → 84.64% (+85%)
Top Buyers
Top Sellers
NVO Hedge Fund Activity: Q2 2013 in Review
411 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2013, worth a combined $5.8B.
Buyers outnumbered sellers: 411 funds opened new NVO positions and 0 closed out — a net gain of 411 holders — while 0 added to existing stakes and 0 trimmed.
- 411 institutional investors held Novo Nordisk (NVO) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $5.8B of Novo Nordisk stock for Q2 2013.
- 411 funds opened new Novo Nordisk positions in Q2 2013 and 0 closed out, a net change of +411 holders.
Based on aggregated 13F filings for Q2 2013.